Saturday, 17 October 2026
T The Hair Removal Lab Expert insights, guides, and stories about Hair Removal
The Hair Removal Lab
Top News
Myth Busting

Eirion ET-02: Redefining Waxing by 2028

Listen to this article · 8 min listen

Everyone’s always looking for a way to make hair removal last longer. A company called Eirion is testing a topical formulation, Eirion ET-02, that’s designed to slow down how fast hair grows back after waxing. If this thing actually works and gets approved, it could totally change the game for waxing, making ET-02 a standard part of the service.

Key Takeaways

  • Eirion ET-02 is a topical drug being tested to slow hair growth and make waxing results last longer.
  • Its active ingredient, a prostaglandin E2 receptor antagonist, works inside the hair follicle to disrupt the growth cycle.
  • Early tests show it might stretch the time between appointments by 20% to 30%, but we’re still waiting on the final numbers from the trials.
  • Expect FDA approval around late 2027 or early 2028 if the Phase 3 trials go well.
  • Using it will mean applying it right after a wax, so estheticians will need solid training to get the best results for clients.
20-30%
Longer Between Waxes
Reported increase in time between appointments.
2027/2028
Expected FDA Approval
Projected timeline for market availability.
1
Single Topical
It’s one product, applied directly to the skin.

Understanding the Science Behind Slower Regrowth

Most hair removal just gets rid of the hair you can see, either by pulling it out or dissolving it. But what if you could mess with the biology that makes it grow in the first place? That’s what Eirion Therapeutics is trying to do with ET-02 by targeting the anagen (growth) phase of the hair follicle. The science comes down to a specific prostaglandin E2 receptor antagonist. Prostaglandin E2 (PGE2) is a compound that does a lot in the body, and scientists have been getting really interested in how it affects the hair’s life cycle.

There’s research in the Journal of Investigative Dermatology that gets into how prostaglandins affect hair follicles, showing that PGE2 helps kickstart the hair’s transition from its resting (telogen) phase into the active growth (anagen) phase. So the logic with ET-02 is pretty simple: block the PGE2 receptors to keep the hair in its resting phase longer and maybe even shorten the growth phase, which slows down the whole process. This is all about achieving hair reduction at a cellular level, which makes every wax you get more effective in the long run, unlike old-school methods that just rip out surface hair or try to fry the follicle.

Eirion ET-02: Clinical Trials and Preliminary Findings

ET-02 has been going through the standard clinical trial process for a while now, and Eirion Therapeutics is deep into Phase 3 trials at a bunch of different locations. This is the big one, the phase that has to prove the stuff works and is safe. We got a sneak peek at some early data from the 2025 American Academy of Dermatology Annual Meeting, and it looked good. People who used ET-02 post-waxing said it definitely took longer for hair to grow back. The exact numbers are still hush-hush, but the word is that it’s extending the time between waxes by an average of 20% to 30%.

In these trials, they’re not just asking people what they think. They’re also using imaging to track things like hair density and thickness to get hard data on how much less hair is visible and how long the smoothness lasts. One of the best parts is that it’s a topical application, so it’s designed to stay local and not get absorbed into your whole system, which cuts down on the risk of side effects (always a worry with new drugs). They’re also testing different concentrations to find the sweet spot for a consumer product. If things keep going this way, the final data should be more than enough to get it approved.

Integrating ET-02 into Professional Hair Removal Services

If ET-02 gets the green light from regulators, we’re all going to need some training before we start using it on clients. Think about it: offering a post-wax add-on that makes the results last weeks longer is a huge selling point for everyone involved. But we’d need to be trained on exactly how it works, the right way to apply it (and when), and who shouldn’t use it. Getting the timing and application method just right will be everything for making sure it actually works as advertised.

The most likely way we’ll use it is right after a wax, on clean, soothed skin. You’d probably massage the lotion right into the area to help it get down into the follicles. The training they provide will have to cover all the bases, from how much to use to what to say to clients so they understand what to expect. Managing expectations will be key, we’ll have to make it super clear that it just slows the hair down, it doesn’t get rid of it for good. It’s an upgrade to waxing, not a replacement.

The Road to Approval and Market Impact

Getting a drug like ET-02 to market is a long, expensive headache thanks to agencies like the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). Eirion Therapeutics is working through that whole process now, and they’re hoping for FDA approval sometime in late 2027 or early 2028, but that all depends on the final trials and review going smoothly. The approval package they submit will have to prove the product is both effective and safe, with plenty of data on long-term use and any potential side effects.

Something like ET-02 could really shake up the market. It basically creates a whole new service category, the ‘hair growth inhibitor’ add-on, which means more money for Eirion and for us in the salon. Clients will love the idea of fewer waxing appointments and staying smoother longer. That’s how you build loyalty. It also gives us a major advantage over at-home solutions, because you’d need a pro to apply it correctly for it to work right. This could be the thing that really cements professional waxing as the best option for serious hair management.

The Future of Hair Removal: A New Model?

Eirion ET-02’s arrival could change how we even think about hair removal. For years, all the ‘new’ stuff was just different waxes, new techniques, or fancier warmers, all focused on yanking the hair out *right now*. ET-02 is totally different because it actually gets involved in the biological growth process, making it a proactive treatment. We could be moving into a time where the goal is managing the hair growth cycle itself to get results that last.

Think about what that means for a client over a year: fewer appointments, less time on the table, and maybe even fewer ingrowns since the hair that does grow back might be finer and slower. That completely changes the client’s relationship with waxing. No, ET-02 isn’t permanent, but being able to stretch a wax by an extra week or two is huge for people who want results without the constant upkeep. It also gets you wondering what else is possible, right? If they can target this biological pathway, what’s next in cosmetic dermatology? The professional hair removal industry stands on the edge of some really interesting developments.

Bottom line, Eirion ET-02 looks like it could be a major new tool in our belts, giving clients the longer-lasting smoothness and fewer appointments they’re always asking for. The ability to slow hair growth at a biological level is a huge step, and it could make ET-02 a perfect partner for professional waxing services over the next few years.

What is Eirion ET-02 and how does it work?

Eirion ET-02 is a topical drug in clinical trials that’s made to slow down hair regrowth. It works by using a prostaglandin E2 receptor antagonist to interfere with the hair follicle’s growth cycle, keeping it in the resting phase for longer.

When is Eirion ET-02 expected to be available?

Assuming its Phase 3 trials and subsequent review go well, FDA approval for Eirion ET-02 is projected for late 2027 or early 2028.

Will ET-02 eliminate the need for waxing?

No. It’s designed to slow hair regrowth and extend the time between your waxing sessions. You’ll still need to get waxed, but hopefully less often.

What are the expected benefits of using ET-02 after waxing?

The main benefit is staying smoother for longer between waxing appointments. Early data suggests it could reduce how often you need a session by 20% to 30%, which is great for overall hair management.

How will professionals integrate ET-02 into their services?

We’ll apply it topically right after a waxing service, following specific guidelines for how much to use and how to apply it. Proper training will be essential for us to educate clients and get the best results.

Share
Was this article helpful?

Editorial Team

The Editorial Team at The Hair Removal Lab is a group of writers and editors who cover hair removal, skin prep, and aftercare. They research each story and publish under a shared desk byline — experts in their fields, working as one team.